What is upneeq?

Upneeq is a brand name medication that contains the active ingredient oxymetazoline hydrochloride. It is a prescription eye drop used to treat acquired blepharoptosis, also known as droopy eyelids. Upneeq works by stimulating the muscle that raises the upper eyelid, resulting in temporary improvement in eyelid position and reducing the appearance of droopy eyelids.

Upneeq is typically administered as one drop in each eye once daily in the morning. It should be used under the guidance of a healthcare provider, as misuse or overuse can lead to side effects such as eye irritation, dryness, redness, and increased intraocular pressure.

Upneeq is a relatively new medication and was approved by the FDA in 2020 for the treatment of acquired blepharoptosis in adults. It is considered a safe and effective option for improving the appearance of droopy eyelids without the need for invasive surgical procedures.